Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates

International Journal of Antimicrobial Agents

Volumn 43, Issue 5, 2014, Pages 438-441

  Lee, Meng Rui ^a   Ko, Jen Chung ^a   Liang, Sheng Kai ^a   Lee, Shih Wei ^b   Yen, David Hung Tsang ^c   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bacteraemia; Clarithromycin; Mycobacterium abscessus subsp. abscessus; Mycobacterium abscessus subsp. bolletii; Tigecycline

Indexed keywords

CLARITHROMYCIN; TIGECYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DRUG EFFECT; DRUG POTENCY; FEMALE; HUMAN; IMMUNE STATUS; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INFANT; MALE; MIDDLE AGED; MORTALITY; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM MASSILIENSE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; SURGICAL INFECTION; VERY ELDERLY; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; CLASSIFICATION; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PATHOLOGY; TAIWAN; UNIVERSITY HOSPITAL;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; TAIWAN;

EID: 84899522477     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.02.007     Document Type: Article

References (15)

1. D.E. Griffith, T. Aksamit, B.A. Brown-Elliott, A. Catanzaro, C. Daley, and F. Gordin et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 175 2007 367 416
2. W. Hoefsloot, J. van Ingen, C. Andrejak, K. Angeby, R. Bauriaud, and P. Bemer et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study Eur Respir J 42 2013 1604 1613
3. C.C. Lai, C.K. Tan, C.H. Chou, H.L. Hsu, C.H. Liao, and Y.T. Huang et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008 Emerg Infect Dis 16 2010 294 296
4. SC. Leao, E. Tortoli, J.P. Euzéby, and M.J. Garcia Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus Int J Syst Evol Microbiol 61 2011 2311 2313
5. C.K. Tan, C.C. Lai, C.H. Liao, C.H. Chou, H.L. Hsu, and Y.T. Huang et al. Mycobacterial bacteraemia in patients infected and not infected with human immunodeficiency virus, Taiwan Clin Microbiol Infect 16 2010 627 630
6. T. Hamamoto, A. Yuki, K. Naoi, S. Kawakami, Y. Banba, and T. Yamamura et al. Bacteremia due to Mycobacterium massiliense in a patient with chronic myelogenous leukemia: case report Diagn Microbiol Infect Dis 74 2012 183 185
7. E. Tortoli, R. Gabini, I. Galanti, and A. Mariottini Lethal Mycobacterium massiliense sepsis, Italy Emerg Infect Dis 14 2008 984 985 (Pubitemid 351838618)
8. M.R. Lee, A. Cheng, Y.T. Huang, C.Y. Liu, K.P. Chung, and H.C. Wang et al. Performance assessment of the DR TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria J Clin Microbiol 50 2012 3398 3401
9. H.Y. Kim, B.J. Kim, Y. Kook, Y.J. Yun, J.H. Shin, and B.J. Kim et al. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns Microbiol Immunol 54 2010 347 353
10. Clinical and Laboratory Standards Institute Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard 2nd ed. Document M24-A2 2011 CLSI Wayne, PA
11. G. El Helou, R. Hachem, G.M. Viola, A. El Zakhem, A.M. Chaftari, and Y. Jiang et al. Management of rapidly growing mycobacterial bacteremia in cancer patients Clin Infect Dis 56 2013 843 846
12. M.R. Lee, A. Cheng, Y.C. Lee, C.Y. Yang, C.C. Lai, and Y.T. Huang et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates J Antimicrob Chemother 67 2012 222 225
13. R.J. Wallace Jr., B.A. Brown-Elliott, C.J. Crist, L. Mann, and R.W. Wilson Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria Antimicrob Agents Chemother 46 2002 3164 3167
14. C.W. Huang, J.H. Chen, S.T. Hu, W.C. Huang, Y.C. Lee, and C.C. Huang et al. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan Int J Antimicrob Agents 41 2013 218 223
15. Y.C. Huang, M.F. Liu, G.H. Shen, C.F. Lin, C.C. Kao, and P.Y. Liu et al. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing J Microbiol Immunol Infect 43 2010 401 406